CXCL10 and neoplasm: This hypothesis is supported by previous findings that show CXCL10 as a potent angiostatic factor, which inhibit a number of angiogenic activities, including human tumor-derived angiogenesis [48, 49] that can induce the dissociation of newly formed blood vessels even in the presence of angiogenic factors [50].